Safe Surf Rated Back To Home Page Family Friendly Site
About
Bradford
  HIV/AIDS
Articles
  Alternative
Therapies
  HIV/AIDS
Videos
  HIV/AIDS
Links
  HIV/AIDS
News

Introduction:
Positively Positive
- Living with HIV
  Out
About
HIV
  Resume/
Curriculum Vitae:
HIV / AIDS Involvements
  Biography   HIV/AIDS
News Archive
HIV/AIDS News Bradford McIntyre
   



CLINILABS SELECTED FOR A PHASE I/II STUDY OF HIV VACCINE

New York, NY (September 3, 2010) - Clinilabs,a contract research organization that provides early-stage and specialty clinical drug development services to industry, announced today that they have been selected to conduct a Phase I/II clinical research study of an investigational vaccine for HIV.

Enrollment for this study is expected to begin later this month. Individuals in the New York City Metro area who are interested in participation may contact our dedicated recruitment staff at 212-994-4567 to prequalify. Healthy adult volunteers as well as HIV positive individuals who have a T-Cell count of 500 or more, may be eligible. Additional information may also be found by visiting www.clinilabs.com/volunteers. www.clinilabs.com/volunteers .

About Clinilabs

Clinilabs is a contract research organization (CRO) that provides early-phase and specialty clinical drug development services to industry. We offer teams, processes, and technology solutions that are designed to serve single center and multicenter early-phase studies - services that can be scaled as needed to meet the requirements of any clinical development program. For more information, visit www.clinilabs.com .

###

 

CONTACT:

Jeanine Estrada
Clinilabs Inc
646-450-2215
jestrada@clinilabs.com



Source: CLINiLABS
http://www.clinilabs.com/About_Us/Media_Center/Releases/HIV_StudyAward.html


...positive attitudes are not simply 'moods'

Site Map

Contact Bradford McIntyre.

Web Design by Trevor Uksik

Copyright © 2003-2017 Bradford McIntyre. All rights reserved.

DESIGNED TO CREATE HIV & AIDS AWARENESS